Puma Biotechnology's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Puma Biotechnology is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is €-0.20. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 72.18M	$ 56.12M	$ 54.57M	$ 46.79M	$ 65.67M
Gross Profit	$ 47.85M	$ 42.83M	$ 42.71M	$ 65.99M	$ 48.84M
EBIT	$ 16.16M	$ 9.35M	$ 5.64M	$ 4.86M	$ 9.81M
EBITDA	$ 19.05M	-	$ 0.00	$ 7.74M	$ 12.02M
Net Income Common Stockholders	$ 12.27M	$ 5.80M	$ 2.13M	$ 98.22M	$ -5.61M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 95.94M	$ 85.03M	$ 74.44M	$ 71.22M	$ 81.07M
Total Assets	$ 230.53M	$ 203.60M	$ 200.49M	$ 195.24M	$ 220.91M
Total Debt	$ 111.49M	$ 112.22M	$ 112.94M	$ 113.64M	$ 114.28M
Net Debt	$ 15.55M	$ 27.19M	$ 38.50M	$ 42.42M	$ 33.21M
Total Liabilities	$ 177.09M	$ 164.86M	$ 170.09M	$ 169.24M	$ 222.06M
Stockholders Equity	$ 53.44M	$ 38.74M	$ 30.40M	$ 25.85M	$ 21.61M
Cash Flow	-
Free Cash Flow	$ 10.41M	-	-	$ -9.86M	$ 7.68M
Operating Cash Flow	$ 10.46M	$ 10.62M	-	$ 2.64M	$ 7.68M
Investing Cash Flow	$ -8.17M	$ 11.18M	-	$ -17.45M	$ -11.87M
Financing Cash Flow	-	-	-	-	$ 2.43M

Currency in USD

Puma Biotechnology Earnings and Revenue History

Income Statement >

Puma Biotechnology Debt to Assets

Balance Sheet >

Puma Biotechnology Cash Flow

Cash Flow >

Puma Biotechnology Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing